- Home
- IMNN vs INBS Comparison
IMNN vs INBS Comparison
Compare IMNN & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- INBS
- Stock Information
- Founded
- IMNN 1982
- INBS 2016
- Country
- IMNN United States
- INBS United States
- Employees
- IMNN N/A
- INBS N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- IMNN Health Care
- INBS Health Care
- Exchange
- IMNN Nasdaq
- INBS Nasdaq
- Market Cap
- IMNN 12.1M
- INBS 11.7M
- IPO Year
- IMNN 1985
- INBS N/A
- Fundamental
- Price
- IMNN $5.75
- INBS $1.79
- Analyst Decision
- IMNN Buy
- INBS
- Analyst Count
- IMNN 2
- INBS 0
- Target Price
- IMNN $182.61
- INBS N/A
- AVG Volume (30 Days)
- IMNN 55.7K
- INBS 127.5K
- Earning Date
- IMNN 11-06-2025
- INBS 11-06-2025
- Dividend Yield
- IMNN N/A
- INBS N/A
- EPS Growth
- IMNN N/A
- INBS N/A
- EPS
- IMNN N/A
- INBS N/A
- Revenue
- IMNN N/A
- INBS $3,052,532.00
- Revenue This Year
- IMNN N/A
- INBS $778.48
- Revenue Next Year
- IMNN N/A
- INBS N/A
- P/E Ratio
- IMNN N/A
- INBS N/A
- Revenue Growth
- IMNN N/A
- INBS N/A
- 52 Week Low
- IMNN $4.83
- INBS $1.10
- 52 Week High
- IMNN $41.22
- INBS $2.75
- Technical
- Relative Strength Index (RSI)
- IMNN 36.86
- INBS 62.21
- Support Level
- IMNN $5.53
- INBS $1.65
- Resistance Level
- IMNN $5.89
- INBS $1.78
- Average True Range (ATR)
- IMNN 0.32
- INBS 0.11
- MACD
- IMNN 0.07
- INBS 0.03
- Stochastic Oscillator
- IMNN 23.81
- INBS 92.86
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).